Can alpha lipoic acid protect kidneys from colistin?
Part of Kidney & urinary clinical trials.
This trial tests whether taking alpha lipoic acid (an antioxidant) can protect the kidneys from damage caused by the strong antibiotic colistin. It is for adults with serious infections who are already receiving colistin through an IV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently receiving colistin through an IV for at least 3 days.
- You have a bacterial infection that is resistant to many antibiotics.
- You do not have chronic kidney disease, are not on dialysis, and have not had a kidney transplant.
- You are not taking other medications that could harm the kidneys, such as vancomycin or gentamicin.
- You are not taking other antioxidants like vitamin C, vitamin E, or N-acetyl cysteine.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.
This trial tests whether taking vitamin C and coenzyme Q10 can help protect your kidneys from damage caused by certain chemotherapy drugs (cisplatin and gemcitabine). It may be an option if you are about to start chemotherapy for cancer and have healthy kidneys.
This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.
This trial tests if alpha lipoic acid, a common supplement, can help reduce stress on the body for children who are on regular hemodialysis. It may offer a way to support their health during treatment.
This study aims to find the best dose of the antibiotic colistin for premature babies (born before 37 weeks) in the neonatal intensive care unit who have a serious infection that is resistant to other antibiotics. The goal is to treat the infection effectively while reducing the risk of kidney damage.
This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.
Hear when a new Nephrotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.